Ontology highlight
ABSTRACT: Background
We recently have shown that Charged multivesicular protein/Chromatin modifying protein1A (Chmp1A) functions as a tumor suppressor in human pancreatic tumor cells. Pancreatic cancer has the worst prognosis of all cancers with a dismal 5-year survival rate. Preclinical studies using ATRA for treating human pancreatic cancer suggest this compound might be useful for treatment of pancreatic cancer patients. However, the molecular mechanism by which ATRA inhibits growth of pancreatic cancer cells is not clear. The objective of our study was to investigate whether Chmp1A is involved in ATRA-mediated growth inhibition of human pancreatic tumor cells.Results
We performed microarray studies using HEK 293T cells and discovered that Chmp1A positively regulated Cellular reti
SUBMITTER: Li J
PROVIDER: S-EPMC3152783 | biostudies-literature | 2009 Feb
REPOSITORIES: biostudies-literature